On November 4, 2021, Valisure announced the detection of high levels of benzene, a known human carcinogen, in several brands and batches of antiperspirant body sprays, regulated as drug products by the FDA, and deodorant body sprays, generally regulated as cosmetics.
Valisure analyzed 108 unique batches from 30 different brands. Even within a single brand, significant batch-to-batch variability was observed:
Full Petition & Supporting Documents:
Media Coverage Highlights:
On November 4, 2021, Valisure announced the detection of high levels of benzene, a known human carcinogen, in several brands and batches of antiperspirant body sprays, regulated as drug products by the FDA, and deodorant body sprays, generally regulated as cosmetics.
Valisure analyzed 108 unique batches from 30 different brands. Even within a single brand, significant batch-to-batch variability was observed:
Full Petition & Supporting Documents:
Media Coverage Highlights:
On November 4, 2021, Valisure announced the detection of high levels of benzene, a known human carcinogen, in several brands and batches of antiperspirant body sprays, regulated as drug products by the FDA, and deodorant body sprays, generally regulated as cosmetics.
Valisure analyzed 108 unique batches from 30 different brands. Even within a single brand, significant batch-to-batch variability was observed:
Full Petition & Supporting Documents:
Media Coverage Highlights:
On November 4, 2021, Valisure announced the detection of high levels of benzene, a known human carcinogen, in several brands and batches of antiperspirant body sprays, regulated as drug products by the FDA, and deodorant body sprays, generally regulated as cosmetics.
Valisure analyzed 108 unique batches from 30 different brands. Even within a single brand, significant batch-to-batch variability was observed:
Full Petition & Supporting Documents:
Media Coverage Highlights: